Medical Marijuana Archives - New Frontier Data

09Jun

Missouri’s Medical Cannabis Program Proceeding Apace

Comments are off for this post

By Peter K. Andreone, Hoban Law Group Missouri’s medical cannabis program prepared to take a giant leap forward this past week: On Tuesday, the Missouri Department of Health and Senior Services (DHSS) published its finalized rules and regulations to govern the state’s medical marijuana program, as well as official application forms to obtain licensure. Updated […]

09Dec

Pain, Pain, Go Away: Cannabis and the Medical Consumer

Posted by Craig Boyte

Marijuana Insights, Medical

Comments are off for this post

By J.J. McCoy, Senior Managing Editor, New Frontier Data America is in pain. In fact, according to the National Institutes of Health, among all U.S. adults, nearly 40 million (17.6%) report suffering from severe pain, while about 25.3 million (11.2%) complained of experiencing daily pain throughout the previous three months. Chronic pain is more than […]

26Aug

Growth Strategy for the Green Ocean

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

Setting a new path for market entry into the cannabis industry Cannabis operators who want to shape the future of legal consumption in the United States want to create innovative new products, reach broad new customer sets, and promote positive uses for cannabis to meet the $80 billion market opportunity the industry is chasing. While cannabis […]

05Aug

Up in Smoke: Alpenglow Botanicals, LLC V. United States

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

Challenging IRS authority to deny “ordinary and necessary” business expense deductions By Tosin Hassan, CPA, CohnReznick In the words of Lauryn Hill, “It’s funny how money changes a situation, miscommunication leads to complication.” With the explosion of cannabis businesses across the country, many business owners are not profitable because of significant tax bills impacting cannabis […]

22Jul

Beware! Are you in compliance with your cash payments?

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

By Mary Amato, CPA, Partner, CohnReznick It is no secret that the Internal Revenue Service (IRS) is aggressively auditing cannabis businesses. The focus is on more than the limitations placed on the industry by IRC §280E. The IRS aggressively audits non-compliance of Reporting of Cash Payments. Form 8300, is not an income tax reporting form. […]

08Jul

The Patton Family, Green Meadows Farm, and a Commitment to Giving Back

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

Historic Massachusetts farm cultivates medical cannabis with a social conscience By Michael Harlow, CPA, Partner Beginning decades ago, George and Joanne Patton, son and daughter-in-law of the famed World War Two general, initiated traditions of community partnership and support that remain active today. Throughout their thirty-year operation of Green Meadows Farm, they sought to share […]

03Jun

Questions and Answers with an Original Licensee Holder

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

A discussion of growing pains, regulations, and current product investments By Michael Harlow, CPA, Partner CohnReznick Partner Michael Harlow: Brian, you were one of the first operational dispensaries in Colorado. What is the single largest difference between the early days and now? Brian Rogers: We started in 2009 with one of the first medical marijuana […]

28Apr

How Cannabis Industry Participants Would Benefit if 280E is Rolled Back

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

By Michael Harlow, CPA, Partner 280E is the Internal Revenue Code section that has been the focus of every tax discussion related to the cannabis industry for the past 15 years. It is the Code section that prohibits cannabis companies from deducting any ordinary and necessary business expenses from gross profit when calculating federal taxable […]

08Apr

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

Posted by Bertie Song

Marijuana Insights

Comments are off for this post

By Greg Chin, Kevin Michaelan and Jeffrey Michelson, Partner Continuing with the topic of industry trends from our last post, we explore the art of acquisition-side due diligence from full-scope financial and tax to limited-scope tax-only engagements. We’ll look at what to expect and how to approach it. Although commonly geared toward the investor/acquirer, i.e., […]

26Mar

Medical Cannabis, Texas-Style: Conditions and Requirements for Use

Posted by Chris Hudock

Marijuana Insights

Comments are off for this post

By Ashley Simpson, Hoban Law Group In 2015, the Texas legislature’s passage of the Texas Compassionate Use Act (Senate Bill 339) legalized medical cannabis in the Lone Star State, but only to the extent of “low-THC cannabis oil” for use by patients diagnosed with intractable epilepsy. Widening further access to any patients respectively diagnosed with […]

Filtered by tag "Medical Marijuana"

Missouri’s Medical Cannabis Program Proceeding Apace

Pain, Pain, Go Away: Cannabis and the Medical Consumer

Growth Strategy for the Green Ocean

Up in Smoke: Alpenglow Botanicals, LLC V. United States

Beware! Are you in compliance with your cash payments?

The Patton Family, Green Meadows Farm, and a Commitment to Giving Back

Questions and Answers with an Original Licensee Holder

How Cannabis Industry Participants Would Benefit if 280E is Rolled Back

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

Medical Cannabis, Texas-Style: Conditions and Requirements for Use